alexa
Reach Us +1-217-403-9671
BCS-Based Biowaivers: Which Drugs Are Eligible? | 19779
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th World Congress on Bioavailability and Bioequivalence Pharmaceutical R&D Summit

Anita Nair
ScientificTracks Abstracts: J Bioequiv Availab
DOI: 10.4172/0975-0851.S1.017
Abstract
I nterchangeability of pharmaceutically equivalent multisource drug products can be evaluated by bioequivalence studies. Generally pharmacokinetic, pharmacodynamic or clinical studies involving human subjects are used for bioequivalence evaluation. However, improved understanding of the biopharmaceutical and clinical parameters of drug products has helped pharmaceutical scientists to utilize in vitro dissolution testing as a method to evaluate bioequivalence in lieu of in vivo bioequivalence studies. The term ?biowaiver? is used to describe the use of surrogate in vitro method to waive the need for in vivo assessment. The concept of biowaiver is based on the Biopharmaceutics Classification System (BCS) and evaluates the biopharmaceutical and clinical parameters of the active pharmaceutical ingredient and the drug product along with the risks associated with the decision of bioequivalence based on in vitro method. Biowaiver approach provides the advantage of circumventing expensive and time consuming in vivo human studies thus reducing the time to bring multisource drug product into the market
Biography
Anita Nair is a Pharmacist and has a Masters degree from the University of Mumbai, India. She completed her PhD in Pharmaceutical Technology from Goethe University, Frankfurt where she worked extensively on biowaiver concept of drug products and published several biowaiver monographs. She is presently heading the solubility and physico-chemical characterization department at Merck in Germany
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version